Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós-Ginès, Ana Clemente-Sánchez, Hugo López-Pelayo, Ramón Bataller

Clin Mol Hepatol. 2025;31(Suppl):S112-S133. Published online October 31, 2024

DOI: https://doi.org/10.3350/cmh.2024.0709

View: 1507 Download: 228 Crossref: 2

Soon Sun Kim, Jae Youn Cheong

Clin Mol Hepatol. 2025;31(1):316-318. Published online October 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0847

View: 766 Download: 51

Anja Geerts, Sander Lefere

Clin Mol Hepatol. 2023;29(Suppl):S276-S285. Published online December 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0373

View: 4989 Download: 155 Web of Science: 10 Crossref: 12

Youxin Wang, Noriko Oza, Jazleen Leo, Ashok Choudhury, Daniel Q. Huang

Received February 5, 2025 Accepted February 6, 2025

DOI: https://doi.org/10.3350/cmh.2025.0133 [Accepted]

View: 413 Download: 34

1 |

Viewed By 6936	MAFLD: How is it different from NAFLD?
Viewed By 6174	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5291	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5139	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4657	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search